LipoD293™ In Vitro DNA Transfection Reagent

SKU:BHT2200061
Research Validated
Overview
Click light‑blue chips for details
LipoD293™ In Vitro DNA Transfection Reagent is an in vitro DNA transfection reagent from SignaGen Laboratories for delivering plasmid DNA into mammalian cells for transient or stable expression. A general-purpose formulation; a short optimization panel is recommended for a new cell type.
Transfection Type DNA Transfection
Application Setting In Vitro
Formulation General-Purpose
Storage 4 °C
Shelf Life 12 months
Options selector
Catalog no. Size
SL100668-0P1ML 0.1 mL
SL100668-0P5ML 0.5 mL
SL100668-1P0ML 1.0 mL
SL100668-1P0MLX5 1.0 mL x 5
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: 4 variants available — select size from the variant selector.
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Store at 4 °C. When stored under recommended conditions, the product is stable for 12 months or longer.
  • Shipping: Please contact us to confirm shipping conditions for this product.
  • Upon receipt: refrigerate upon receipt.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Storage 4 °C
Catalog no. (Mfr.) SL100668
Main SKU BHT2200061

Product Overview

SignaGen's innovative, proprietary lipid conjugation technology underlies LipoD293™ (Ver. II), whose design and proprietary enhancers aim at highly efficient DNA transfection in HEK293 cells along with other mammalian cell types. From this second-generation liposome-based DNA transfection reagent SignaGen reports exceptionally high transfection efficiency in HEK293-derived cells and in many other mammalian cells, cytotoxicity staying low throughout.

Refined chemistry separates it from the previous formulation and brings a 3–4 fold improvement in gene delivery efficiency. Approximately 666 transfections in 24-well plates, or 333 in 6-well plates, can be run from one 1.0 mL vial of LipoD293™ (Ver. II) Reagent.

LipoD293™ In Vitro DNA Transfection Reagent – schematic of enhanced gene delivery
Figure 1. Schematic illustration of enhanced gene delivery mediated by LipoD293™ (Ver. II).

Specifications

Transfection Type DNA Transfection
Application Setting In Vitro
Pre-Optimized No — General-Purpose Formulation
Storage Store at 4 °C. When stored under recommended conditions, the product is stable for 12 months or longer.

Features

  • Preferred option for cells that are hard to transfect
  • Supports exceptionally high viral titers
  • Highly effective with very large DNA constructs (up to 180 kb)
  • Works equally well in suspension HEK293 cells (e.g., 293F, 293H)
  • Enables high-level recombinant protein expression
  • Higher transfection efficiency when serum and antibiotics are present in 293 cells
  • Exceptional results with both single-DNA transfection and multi-DNA co-transfection
  • Highly cost-effective transfection option

Performance Data

LipoD293™ In Vitro DNA Transfection Reagent – HepG2 GFP transfection vs L2K and Fugene HD; serum/antibiotic effect
Comparison of transfection efficiency of LipoD293™ reagent (Ver. II) vs. lipofectamine 2000 (L2K) and Fugene HD on HepG2 cells. Right Panel: Comparison of transfection efficiency of LipoD293 (Ver. II) with Lipofectamine 2000 (L2K), and Fugene HD on HepG2 cells. GFP DNA (pEGFP-N3) was transfected with different transfection reagents per the manufacturer’s protocols to HepG2 cell (cultured on collagen-pretreated dishes). GFP-positive cell (%) and fluorescence intensity were detected by passing through FACS 48 hours post-transfection Left Panel: presence of serum and antibiotics enhances LipoD293 (Ver. II) efficiency on HepG2 cells. HepG2 cell (grown on collagen-treated dishes) was transfected with three different conditions——-serum and antibiotics free, presence of 10% serum and antibiotics, followed by removal 5 hours post transfection, and presence of 10% serum and antibiotics without removal 5 hours post transfection.
LipoD293™ In Vitro DNA Transfection Reagent – CHO transfection vs L2K, TransIT and Fugene 6, with price comparison
Comparison of transfection efficiency of LipoD293™ reagent (Ver. II) vs. lipofectamine 2000 (L2K), TransIT and Fugene 6 on CHO cells. Right Panel: Comparison of transfection efficiency of LipoD293 (Ver. II) with Lipofecatmine 2000 (L2K), TransIT and Fugene 6 on CHO cells. DNAs encoding Renilla luciferase (phRL-CMV) and GFP (pEGFP-N3) were transfected with different DNA transfection reagent per the manufacturer’s protocols. Renilla luciferase activity and GFP fluorescence were detected with Renilla Assay System and a Nikon Eclipse fluorescent microscope, respectively, 24 hours post-transfection. Left Panel: Comparison of price ($/1.0 ml vial) of LipoD293 versus those of Lipofecatmine 2000 (L2K), TransIT, and Fugene 6. All the prices were collected from the manufacturers’ websites.
LipoD293™ In Vitro DNA Transfection Reagent – GFP in primary rat aortic smooth muscle cells vs Lipofectamine 2000
A comparison of the transfection efficiency of LipoD293™ reagent with Lipofectamine 2000 (L2K) on a hard-to-transfect cell, primary rat aortic smooth muscle cells. The rat aortic smooth muscle cells were prepared and transfected with pEGFP-N3 by LipoD293™ reagent (left panel) and Lipofectamine 2000 (L2K, right panel), respectively per the manufacturers’ protocols. The transfection efficiency was evaluated by detecting GFP fluorescence with a Nikon Eclipse 2000 microscope 24 hours post-transfection. The above pictures were kindly provided by Dr. Nickolai Dulin of the Section of Pulmonary and Critical Care, University of Chicago.
LipoD293™ In Vitro DNA Transfection Reagent – GFP co-transfection in LNCap cells vs Fugene HD
A comparison of the transfection efficiency of LipoD293™ reagent with Fugene HD on hard-to-transfect cells, LNCap cells. The LNCap cells were grown according to ATCC recommended procedures and co-transfected with pBabe-hygro-SSeCKs (1.5 ug) and pEGFP-N3 (0.5 ug) per well (6-well plate), LipoD293™ reagent (left panel) and Fugene HD (right panel), respectively per the manufacturers’ protocols. The transfection efficiency was evaluated by detecting GFP fluorescence with a Nikon Eclipse 2000 microscope 24 hours post-transfection. The above pictures were kindly provided by Dr. Lyn Gao of Roswell Park Cancer Institute.
LipoD293™ In Vitro DNA Transfection Reagent – GFP in HepG2 and β-galactosidase in SaoS-2 cells
Two examples showing the exceptional efficiency of LipoD293™ reagent on hard-to-transfect cells like HepG2 and SaoS-2 cells. HepG2 and SaoS-2 cells in 95% confluency were transfected with pEGFP-N3 and pSV-β-galactosidase DNAs, respectively in the presence of serum/antibiotics. The efficiency was checked 48 hours post-transfection by Zeiss 510 Confocal Microscopy and β-galactosidase staining kit, respectively.
LipoD293™ In Vitro DNA Transfection Reagent – GFP transfection in HEK293 cells, DIC and FITC imagingLipoD293™ In Vitro DNA Transfection Reagent – HEK293 cells transfected with 293fectin™ for comparison, DIC and FITC imaging
A comparison of the transfection efficiency of LipoD293™ reagent with 293fectin on HEK293 cells. HEK293 cells transfected with the pEGFP-C1 plasmid using LipoD293™ In Vitro DNA Transfection Reagent (Ver. II) (upper panel) and the most popular brand product 293fectin™ of Invitrogen (lower panel). The cells were visualized by Nikon Eclipse Fluorescence microscope with DIC phase imaging (left panel) and FITC imaging (right panel) 24 hours post-transfection.
LipoD293™ In Vitro DNA Transfection Reagent – GFP-His protein production in 293F cells vs 293fectin, Xfect and Fugene 6
A comparison of LipoD293™ reagent vs. 293fectin, Xfect, and Fugene 6 transfection reagents on protein production with suspension 293F cells. 30 mL of 293F cell cultured in standard culture medium was transfected with pEGFP-6xHis plasmid using LipoD293™ In Vitro DNA Transfection Reagent (Ver. II) (20 ug plasmid DNA), 293Fectin (30 ug plasmid DNA), Xfect (30 ug plasmid DNA) and Fugene 6 (30 ug plasmid DNA) per manufacturers’ standard transfection protocols. GFP fluorescence was visualized 48 hours post-transfection (left panel) with A for LipoD293, B for 293fectin, C for Xfect, and D for Fugene 6. The 6xHis tagged GFP protein was then purified via Ni-NTA affinity column. 5 μL of 1st elution fraction was resolved on SDS-PAGE, followed by Coomassie Brilliant Blue staining (right upper panel E) with lane 1 for LipoD293, lane 2 for protein marker, lane 3 for Xfect, lane 4 for 293fectin, and lane 5 for Fugene 6. The protein yield was quantified via a spectrometer (right lower panel F).
LipoD293™ In Vitro DNA Transfection Reagent – lentivirus production in 293FT cells vs Lipofectamine LTX, titer by FACSLipoD293™ In Vitro DNA Transfection Reagent – lentivirus production in 293FT cells vs Lipofectamine LTX, titer by FACS
A comparison of LipoD293™ (Ver. II) and Lipofecatmine LTX (LTX) on the generation of Lentivirus (LV). Three cDNAs were co-transfected with LipoD293™ (Ver. II) and Lipofectamine LTX (LTX) into 293FT cells. A GFP vector, pHR-SIN-cppt-CMVEWP, was used to determine the titer of LV. 1×105 293F cells per well were plated into a 24-well plate followed by the addition of different amounts of the vector supernatant, 1 microliter (upper panel) and 10 microliters (lower panel), respectively. 5 days later, the cells were passed with FACS. The numbers in the upper right corner indicate the percentage of transduced cells. The titers of LV generated with LipoD293™ and L2K were quantified to be 8×10^6 and 3×10^6 tu/ml, respectively

Applications

This DNA transfection reagent supports a range of molecular biology applications including transient and stable transfection, reporter assays, protein expression studies, and gene function analysis in mammalian cell systems.

Safety & Handling

For Research Use Only (RUO) — Not for diagnostic or therapeutic use. Handle reagents according to institutional biosafety guidelines. Refer to the Safety Data Sheet (SDS) for detailed handling and disposal instructions.
Q.What cell types are compatible with LipoD293™ In Vitro DNA Transfection Reagent?
A.This reagent is designed for broad compatibility with mammalian cell lines. Refer to the product datasheet for tested cell lines and optimization guidelines. SignaGen offers pre-optimized versions for specific cell types.
Q.How should I store LipoD293™ In Vitro DNA Transfection Reagent?
A.Store at 4 °C. When stored under recommended conditions, the product is stable for 12 months or longer. Follow the product datasheet for detailed storage and stability information.
Q.Is a detailed protocol available for LipoD293™ In Vitro DNA Transfection Reagent?
A.Yes. A product datasheet and protocol documents are available in the Documents tab. These include step-by-step instructions for transfection setup.
Q.Is this product suitable for diagnostic or therapeutic use?
A.No. This product is for Research Use Only (RUO) and is not intended for diagnostic, therapeutic, or clinical applications.
Q.How can I request pricing for this product?
A.Click "Request special pricing" on the product page or contact BioHippo support. Volume discounts may be available for bulk orders.
Q.Can I use this reagent for stable transfection?
A.Yes. This reagent supports both transient and stable transfection. For stable transfection, apply antibiotic selection 24-48 hours after transfection according to your selection marker.

Can't Find What You're Looking For? We can help you source the best match or customize a transfection solution for your study. Options may include pre-optimized formulations for a cell line not listed here, matching transfection buffer supplied with the reagent, DNA, siRNA or in vivo formats within the same reagent family, and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

Yang L, Renauer P, Tang K, et al.. OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours. Nature (2026). 10.1038/s41586-026-10149-8

Cheung J, Hunt B, Wahed S, et al.. Distinct T cell functions enable efficient immunoediting and prevent tumor emergence of developing sarcomas. Cancer Cell (2025) 43(12), 2311-2326.e4.. 10.1016/j.ccell.2025.09.005

Sun Y, Wang X, Zhang D, et al.. Brain-wide neuronal circuit connectome of human glioblastoma. Nature (2025) 641(8061), 222-231.. 10.1038/s41586-025-08634-7

Despic V, Jaffrey S. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature (2023) 614(7947), 358-366.. 10.1038/s41586-022-05668-z

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today